abstract |
The present invention relates to quinoxalinone derivatives of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in claim 1 as an insulin secretion stimulant. The present invention also relates to the preparation and use of these quinoxalinone derivatives for the treatment and / or prevention of diabetes and related diseases. Other preferred compounds are compounds of formula (I) wherein R 1, R 2, R 3, R 4, R 5 and R 6 can be optionally substituted by one or more groups selected from Z. |